Stantec Inc. STN has delivered an impressive 39% year-to-date gain, sharply outperforming the industry's 6% decline. In contrast, U.S. peers have seen mixed results: Tetra Tech TTEK is down 9%, while AECOM ACM has surged 40.5%.

HES exits Suriname's offshore Block 59, capping years of risky exploration after XOM and EQNR pulled out earlier.

With Bitcoin holding near $109K and optimism rising, V, CME, and BLK emerge as top crypto-exposed stocks to watch now.

Gray Media (GTN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

OPRX, EWCZ and QFIN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 9, 2025.

LVS is doubling down on premium mass gaming in Macau to drive long-term growth despite rising competition.

CGIC offers true international diversification, prioritizing non-US companies and sectors like Financials, Industrials, and IT for global exposure. The ETF has delivered a strong 29.2% price return in its first year, but comes with a higher-than-average 0.54% expense ratio. CGIC focuses on high-quality, dividend-paying companies with healthy financials, aiming to reduce volatility and enhance long-term growth.

Alexandria Real Estate Equities is a best-in-class life sciences REIT trading at a deep discount, with fundamentals intact despite sector headwinds. The current nearly 7% dividend yield and a P/FFO at half its historical average create a compelling value opportunity for patient, long-term investors. Early signs of sector recovery—rising VC funding, employment, and leasing—suggest a bottoming and potential re-rating, especially if interest rates decline in 2026.

NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Open Lending Corporation (NASDAQ: LPRO) breached their fiduciary duties to shareholders.

Vivek Arya, Bank of America senior semiconductor analyst, joins 'Squawk Box' to discuss concerns regarding Nvidia's market capitalization, if there are more 'DeepSeek moments' to come and much more.

CNBC's Angelica Peebles reports on themes emerging in the pharma space.

EAST BRUNSWICK, N.J. & BENGALURU, India--(BUSINESS WIRE)---- $WIPRO #AI--Wipro Limited will announce results for the first quarter ended June 30, 2025, on Thursday, July 17, 2025, after stock market trading hours in India.

GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.

Applied Digital's AI data center leases show promise, but cloud losses and execution risk cloud its path to sustainable margin growth.

Several stocks recently unveiled plans to significantly enhance shareholder value. These plans include the two major types of capital returns that investors often pay attention to: dividends and buybacks.

The three major microchip stocks in this analysis all look as if they are going higher over the longer-term, but they are moving at different paces, as would be expected. Nvidia continues to run hot, while the other two are in the process of turning it up to higher levels.

GOOGL remains a strong buy, trading at just 19x P/E despite robust growth in cloud, AI, and digital ads. Waymo, YouTube, and Cloud businesses alone could conservatively justify a $1.7T valuation, excluding core ads and other segments. AI and cloud momentum are strong, but regulatory, capex, and moonshot risks remain key watchpoints for investors.

President Trump warns of new tariffs that won't be tied to individual countries, but to specific product imports instead.

Pinnacle Financial Partners, Inc. PNFP will release earnings results for the second quarter, after the closing bell on Tuesday, July 15.

A new era of regulation is bound to bring high hopes for the crypto bulls. House Republicans are now gearing up for “Crypto Week” — during which the committee has agreed to prioritize digital asset legislation and review several crypto-related bills.